Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,129
Closed -$1.11M 610
2024
Q4
$1.11M Buy
11,129
+647
+6% +$66.7K 0.5% 42
2024
Q3
$1.19M Sell
10,482
-10,511
-50% -$1.25M 0.36% 94
2024
Q2
$2.6M Buy
20,993
+5,293
+34% +$682K 0.61% 23
2024
Q1
$2.07M Buy
+15,700
New +$1.94M 0.5% 18
2023
Q4
Sell
-13,800
Closed -$1.42M 753
2023
Q3
$1.42M Buy
+13,800
New +$1.49M 0.5% 40

Other funds holding MRK

AXQ Capital's MRK Position: Q1 2025 in Review

AXQ Capital sold out of Merck (MRK) in Q1 2025, closing a stake of 11,129 shares — an estimated $1.11M sold.

AXQ Capital first reported a position in MRK in Q3 2023 and held it in 5 quarters. The position peaked at $2.6M in Q2 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • AXQ Capital reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • AXQ Capital sold 11,129 Merck shares in Q1 2025, an estimated $1.11M.
  • AXQ Capital first reported a position in Merck in Q3 2023 and held it in 5 quarters.
  • AXQ Capital's Merck position peaked at $2.6M in Q2 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on AXQ Capital's 13F filing for Q1 2025, filed 13 May 2025.